Signifor LAR 20 & 40 MG
Ended Awarded
- Contract number
- 36C24526N0111
- Awardee
-
Recordati Rare Diseases Inc. UEI LL38YHW3Y9P4
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $33,680
Award facts
- Contract value 100% obligated
- $33,680.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
About this award
Recordati Rare Diseases Inc. received a firm fixed-price delivery order award of $33.7K from the Department of Veterans Affairs' Veterans Integrated Service Network 5 for Signifor LAR 20 and 40 mg pharmaceutical products. The award was issued on October 20, 2025, with an ultimate completion date of October 21, 2025, and will be performed in Bartlett, Tennessee. This delivery order was placed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with no set-aside designation and represents a specialized pharmaceutical supply to support veteran healthcare services.
This delivery order is executed under Recordati Rare Diseases Inc.'s existing VA federal supply schedule contracts, including a $15.6M multiple-award Indefinite-Delivery Vehicle running through April 2026 and a $3.16M single-award Blanket Purchase Agreement through July 2026. Signifor LAR is a specialized treatment for rare endocrine disorders such as Cushing's disease and acromegaly. As a foreign-owned pharmaceutical manufacturer focused on rare disease treatments, Recordati has consistently supplied critical medications to VA Veterans Integrated Service Networks across multiple regions, demonstrating its established role as a key provider of specialized pharmaceutical products within the federal healthcare system.
Quick answers
Who was awarded contract 36C24526N0111?
36C24526N0111 was awarded to Recordati Rare Diseases Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on October 20, 2025.
How much is contract 36C24526N0111 worth?
The government has obligated $33,680 on 36C24526N0111.
Is contract 36C24526N0111 an order under another contract?
Yes. 36C24526N0111 is a delivery order under 36F79721D0141, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0111 competed?
The extent of competition for 36C24526N0111 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award